DebasishBanerjee St George's University Hospital NHS Foundation TrUnited Kingdom

DebasishBanerjee
Professor Debasish Banerjee is a nephrologist with special interest in cardiovascular complications of chronic kidney disease. He keen on service development and education on heart diseases in CKD particularly heart failure. He established the multidisciplinary CKD-heart failure clinic in St George’s Hospital. His research is on vascular and cardiac changes in CKD, the risk factors and intervention with randomised controlled trials. He is co-Director of the Translational and Clinical Sciences Research Institute at St George’s University of London. He works on various roles for the International Society of Nephrology, European Society of Cardiology and UK Kidney association. He is keen on teaching of undergraduate medical students; currently the Quality lead for MBBS program and joint Head of the Section of Clinical Teachers in St Georges’ University of London.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Innovations in Transplantation
Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD
MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deUniversity hospital ErlangenGermany
  • Update in Robotic Kidney Transplantation
    RajeshSivaprakasam Speaker rajesh.sivaprakasam@nhs.netUnited Kingdom
  • Progress in Xenotransplantation
    MeganSykes Speaker ms3976@cumc.columbia.eduUnited States
  • Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation
    CarolineLamarche Speaker caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
  • Post Transplant TMA-pathogenesis and Management
    LilianMonteiro P. Palma Speaker lilian.palma@icloud.comState University of CampinasBrazil
  • Q and A
Hall A
10:30 a.m.
11 a.m.
Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy
JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria
Hall A
12:15 p.m.
1:15 p.m.
Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session
Domingo Casadei Chairperson drdomingocasadei@gmail.com
VivekanandJha Chairperson vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia
  • How to Achieve Transparent and Regulated Organ Donation and Transplantation
    Maria AmaliaMatamoros Speaker amatamoros@cehcr.comCosta Rica
  • Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism
    LilianaBisigniano Speaker lbisigniano@incucai.gov.arLiliana Bisigniano MDArgentina
  • How to Handle Cases of Presumed Transplant Tourism
    KenSakai Speaker kensakai@med.toho-u.ac.jpDepartment of Nephrology, Toho University Omori Medical CenterJapan
  • Q and A
Hall C1
2:45 p.m.
3:30 p.m.
What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C)
ErangaWijewickrama Spotlight Chairperson Faculty of Medicine, University of ColomboSri Lanka
Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala
Magdalena Madero Spotlight Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia
NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka
Spotlight Stage 1 (exhibition hall)
3 p.m.
4 p.m.
Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itInternational Renal Research Institute of VicenzaItaly
  • Q and A
Hall D
4 p.m.
4:30 p.m.
Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker uptal@hibio.comUnited States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
New Developments in CKD Epidemiology Research
MaartenTaal Chairperson University of NottinghamUnited Kingdom
RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
  • Big Data Lab
  • Patient-reported Outcome Measures: How Do Patients Experience CKD?
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
  • Trial Simulation Using Observational Data
    AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States
  • Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
    DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukLondon School of Hygiene & Tropical MedicineUnited Kingdom
  • Q and A
Hall C4

Day 2 - Monday April 15, 2024

Time Session
12:15 p.m.
1:15 p.m.
The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management
RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
  • Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease
    MarisolTorres Toledano Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    DebasishBanerjee Speaker dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States
  • Q and A
Hall C1

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10 a.m.
Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment
DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom
MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Setting the Scene
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • DM and CKD: Which Treatment Should I Use for Different Populations?
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • How to Design Studies on Answering Unanswered Questions
    VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
  • The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Q and A
Hall C4